Tempest Therapeutics, Inc. Property, Plant and Equipment, Gross
Tempest Therapeutics, Inc. (TPST) had Property, Plant and Equipment, Gross of $2.06 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-13
- 2026-06-30: Property, Plant and Equipment, Gross $2.06M.
- 2026-03-31: Property, Plant and Equipment, Gross $2.06M.
- 2025-12-31: Property, Plant and Equipment, Gross $2.06M.
- 2025-09-30: Property, Plant and Equipment, Gross $2.20M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2026-06-30 | $2.06M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $2.06M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $2.06M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $2.20M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $2.20M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $2.21M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $2.21M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $2.30M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $2.28M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $2.03M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $1.86M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $2.57M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $2.57M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $2.50M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $2.42M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $2.16M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $2.06M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $1.96M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $1.94M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $1.84M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $1.84M 10-Q · filed 2021-08-12 | |
| 2020-12-31 | $1.57M 10-K · filed 2022-03-29 | |
| 2018-09-30 | $1.78M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $2.26M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $6.96M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $6.81M 10-Q · filed 2018-11-09 | |
| 2017-09-30 | $7.65M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $7.87M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $8.98M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $9.00M 10-K · filed 2018-03-15 | $9.19M 10-K · filed 2017-03-02 |
| 2016-09-30 | $12.07M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $11.60M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $11.59M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $10.73M 10-K · filed 2017-03-02 | |
| 2015-09-30 | $8.60M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $5.76M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $5.50M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $4.50M 10-K · filed 2016-02-26 | |
| 2014-09-30 | $4.05M 10-Q · filed 2014-11-10 | |
| 2013-12-31 | $1.57M 10-K · filed 2015-03-16 | |
| 2012-06-30 | $456.00K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |